Navigation Links
Medical Researchers Say They Have Made a Breakthrough That Could Lead to a Potential Cure for AIDS
Date:9/1/2013

Auckland, NZ (PRWEB) September 01, 2013

Dr Richard Teague, spokesperson for Regenex Laboratories, says they have discovered how to use selected proteins within an ovine placenta extract base and combine it with peptides and signaling molecules designed to ‘wake up’ dormant stem cells in the body.

"Peptides are considered the future of medicine," he said. "And with this technology, using fractionated OVP in combination with peptides, we can provide an answer to HIV by reactivating the patient’s immune system."

"Up until now these products have only used in the controversial anti-ageing field, but now we have evidence that they actually do re-activate a person's stem cells. The stem cells are intelligent in that they seek out the area of most need in the body and repair it."

Dr Teague says the injectable cannot eradicate HIV from the body but it could potentially end the disease, as it provides a healthy immune system so patients can handle normal infections."

More than 33 million people have been diagnosed with HIV worldwide.

If clinical trials are successful, one initial 12 week course followed by a single dose every 3-4 months could be effective enough to replace the multiple therapies they currently need.

The key to the Immune Booster IM product is the filtering process which is used in the production process. The company has been able to achieve a filtration of less than 50,000 Dalton units, meaning the 5mg dose can be safely injected intramuscular, rather than having to be done intravenously.

"We have spent several years developing the production process and this is cutting edge technology now available to consumers worldwide."

"With HIV you have 2 options. You either have to eliminate the virus infection from the body, or you have to provide the body a mechanism by which it can naturally fight off simple diseases which to a HIV sufferer can be fatal. Immune Booster IM does that by activating dormant stem cells."

Dr Teague says that while the product is readily available now for anti ageing, and other conditions such as Rheumatoid arthritis and crones disease, the product is yet to undergo trials for HIV.

"This particular study is going to take some time, but so far every test that we have put this product through has passed with flying colors, and we have enough initial human tests results to know we have something special here," he said.

Successful clinical trials would present a rare bright spot in the ongoing battle against HIV. In August this year, U.S. trials for a potential AIDS vaccine were called off after the National Institute of Allergy and Infectious Diseases found the treatment — HVTN 505 —statistically ineffective compared to a placebo. (A cure differs from a vaccine in that the former works on people who have already contracted the virus.)

Immune Booster IM will be marketed as a cure since early trials indicate it has the ability to completely reverse the AIDS potency in the body, by boosting T-Cell counts and decreasing viral load. This comes about by the body itself fighting off the disease, after being re-activated by the Immune Booster IM.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11082049.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Physician Groups Call for Fewer Medical Tests
2. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
3. CAM therapy combined with conventional medical care may improve treatment of lower back pain
4. Image share project gives patients and physicians anytime, anywhere access to medical images
5. Researchers determine vitamin D blood level for reducing major medical risks in older adults
6. Biomedical researchers receive Hartwell Foundation awards
7. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
8. Fitness in Middle Age Lowers Medical Costs Later: Study
9. Ben-Gurion U. and Cincinnati Childrens Hospital to develop pediatric-specific medical technologies
10. Gene Tests May Not Drive Patients to More Medical Care
11. University studies and career expectations of medical students
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new ... at MIBio 2017 in Cambridge, U.K on ... in biopharmaceutical samples with unprecedented speed and sensitivity while using far ... Membrane Imaging. ... particle analysis system ...
Breaking Medicine Technology: